Search Results - mary+maral+mouradian

2 Results Sort By:
Novel Gene Therapy to Treat L-DOPA-Induced Dyskinesia
Viral vector injections of rAAV-∆FosB shRNA significantly reduced abnormal involuntary movements (AIMs) compared to control vector in a rat model of Parkinson’s disease.Invention Summary:Parkinson's disease (PD) is a progressive, debilitating, and currently incurable neurodegenerative disease. Long-term dopamine replacement therapy in PD leads...
Published: 12/8/2021   |   Inventor(s): Mary Maral Mouradian, Stella Papa
Keywords(s): Neurological disorder & neuropathic pain
Category(s): Technology Classifications > Healthcare & Life Sciences, Technology Classifications > Gene Therapy, Technology Classifications > Therapeutics
Synergistic use of Coffee Components to Reduce Risk of Parkinson & other Neurodegenerative Diseases
Synergistic neuroprotection by two coffee components (EHT/Caffeine) to slow down progression of Parkinson’s Disease and Dementia with Lewy Bodies Invention Summary:Parkinson's disease (PD) is the second most common neurodegenerative disorder, and Dementia with Lewy bodies (DLB) is the second most common type of dementia after Alzheimer’s...
Published: 12/8/2021   |   Inventor(s): Mary Maral Mouradian, Jeffry Stock
Keywords(s): Neurological disorder & neuropathic pain
Category(s): Technology Classifications > Healthcare & Life Sciences, Technology Classifications > Food, Nutrition and Nutraceuticals
[%Analytics%]